We investigated the clinical relevance of SYNGR2 in the different tumor types using Kaplan–Meier survival analysis (Fig. 3A; Additional file 1: Figs. S1–S4) regarding OS, DSS, DFI, and PFI. The gene discussed is SYNGR2; the disease is neoplasm.